Patient Retention, Compliance Ads Should Be Larger Part Of DTC Spend, Consultant Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Increased compliance would improve product sales, DTC Perspectives CEO Ehrlich tells a conference on direct-to-consumer advertising in Boston. Pharma companies spent $3.48 bil. on DTC in 2003, 95% of which went toward branded ads.